Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

secukinumab × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 531 Specimen Handling 516 Magnetic Resonance Spectroscopy 428 Carboplatin 343 Cyclophosphamide 324 Biopsy 300 Cisplatin 287 Paclitaxel 257 Nivolumab 244 Gemcitabine 227 Radiotherapy 226 Bevacizumab 190 Dexamethasone 187 fludarabine 181 venetoclax 175 Docetaxel 156 Oxaliplatin 153 atezolizumab 150 durvalumab 148 Fluorouracil 148 Rituximab 142 Pemetrexed 141 Capecitabine 138 Doxorubicin 128 Standard of Care 125 Radiation 125 Lenalidomide 124 Drug Therapy 121 Radiosurgery 118 Prednisone 117

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07237594 2026-03-11

REPLAY

Duke University

Phase 1 Not yet recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡